obesity-995x60.png
FEATURED ARTICLES
Long-Distance Rare Disease Trials: Why PLL Landed On Australia And New Zealand
Australia and New Zealand had a lot to offer PLL Therapeutics, but speed and savings aren't the only upsides for running its rare disease trial from its European home.
-
![two same digital person-GettyImages-964835390]( "How Digital Twins Are Reshaping Clinical R&D")
How Digital Twins Are Reshaping Clinical R&DDiscover how digital twins are helping predict outcomes, streamline recruitment, reduce patient burden, and accelerate clinical development.
-
![hand holding credit card, laptop-GettyImages-2207149857]( "Why Are We Still Talking About Compensating Research Participants?")
-
![Senior woman meeting with doctor-GettyImages-2205398466]( "Examining The Potential Of P-tau217 To Provide Earlier Diagnosis Of Alzheimer's")
Examining The Potential Of P-tau217 To Provide Earlier Diagnosis Of Alzheimer'sP-tau217 blood tests could accelerate Alzheimer’s diagnosis. Lilly’s Nino Sireci, MD, MSc, explains the research, evidence thus far, potential clinical use, and next steps.
SERVICES AND PRODUCTS
Explore the breadth of Altasciences’ expertise in clinical pharmacology studies, supporting regulatory submissions across a diverse range of therapeutic areas.
Managing clinical trial disclosure can be challenging with the ever-evolving regulatory landscape, and varying requirements across different jurisdictions and regulatory bodies. New and updated regulations need to be continuously monitored and assessed for potential impact on an organization, processes and overall strategy.
Ypsomed accelerates clinical progress by reducing barriers across clinical development, enabling earlier study readiness, greater visibility and more informed decisions.
DECODE, the Digital Endpoint Collaboration for Outcomes Development, is Ametris’ pre-competitive collaboration framework designed to help address shared clinical measurement challenges across the life sciences industry. In regulatory contexts where evidence expectations are high, digital measures must be meaningful to patients, scientifically valid, operationally feasible, and aligned with regulatory expectations. By supporting the development and validation of fit-for-purpose, patient-centered digital measures, DECODE helps transform real-world data into validated clinical evidence across clinical research programs.